You have 9 free searches left this month | for more free features.

Ruxolitinib,

Showing 1 - 25 of 345

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

GVHD, Acute Stem Cell Transplant Complications Trial in Chendu (Ruxolitinib)

Not yet recruiting
  • GVHD
  • Acute Stem Cell Transplant Complications
  • Chendu, Sichuan, China
    West China Hospital, Sichuan University
Oct 3, 2023

The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA Trial (Ruxolitinib 5 MG BID Oral Tablet)

Not yet recruiting
  • The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
  • Ruxolitinib 5 MG BID Oral Tablet
  • (no location specified)
Jun 13, 2023

Ruxolitinib in Patients With Myelofibrosis

Not yet recruiting
  • Myelofibrosis
  • (no location specified)
Feb 28, 2023

Neuromyelitis Optica Spectrum Disorder Relapse Trial in Tianjin (Ruxolitinib)

Withdrawn
  • Neuromyelitis Optica Spectrum Disorder Relapse
  • Tianjin, Tianjin, China
    Tianjin Medical University General Hospital
Jun 10, 2023

Hand Eczema Trial (Ruxolitinib cream, Vehicle)

Not yet recruiting
  • Hand Eczema
  • (no location specified)
Jun 7, 2023

Graft-versus-host Disease (GVHD) Trial (Ruxolitinib)

Approved for marketing
  • Graft-versus-host Disease (GVHD)
  • (no location specified)
Jan 26, 2023

Haemophagocytic Lymphohistiocytosis Trial (Ruxolitinib)

Not yet recruiting
  • Haemophagocytic Lymphohistiocytosis
  • (no location specified)
Feb 28, 2023

Metastatic Triple-Negative Breast Carcinoma, Breast Cancer Trial in Dallas (Neratinib Oral Tablet, Ruxolitinib Oral Tablet)

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • Breast Cancer
  • Neratinib Oral Tablet
  • Ruxolitinib Oral Tablet
  • Dallas, Texas
    Baylor University Medical Center, Baylor Charles A Sammons Cance
Aug 22, 2023

Seborrheic Dermatitis Trial in New York (Ruxolitinib 1.5% Cream)

Recruiting
  • Seborrheic Dermatitis
  • Ruxolitinib 1.5% Cream
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Mar 15, 2023

Prurigo Trial (Ruxolitinib Cream, Vehicle Cream)

Not yet recruiting
  • Prurigo
  • Ruxolitinib Cream
  • Vehicle Cream
  • (no location specified)
Feb 23, 2023

Prurigo Nodularis Trial (Ruxolitinib Cream, Vehicle Cream)

Not yet recruiting
  • Prurigo Nodularis
  • Ruxolitinib Cream
  • Vehicle Cream
  • (no location specified)
Mar 1, 2023

Nonsegmental Vitiligo With Genital Involvement Trial (Ruxolitinib Cream)

Not yet recruiting
  • Nonsegmental Vitiligo With Genital Involvement
  • Ruxolitinib Cream
  • (no location specified)
Feb 20, 2023

Severe Aplastic Anemia, Single Lineage Cytopenias, T-LGL, Hypoplastic MDS Trial run by the National Heart, Lung, and Blood

Not yet recruiting
  • Severe Aplastic Anemia
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 23, 2023

Vitiligo Trial in Nice (Ruxolitinib Topical, Placebo)

Not yet recruiting
  • Vitiligo
  • Ruxolitinib Topical
  • Placebo
  • Nice, Alpes-maritimes, France
    CHU de Nice - Hôpital de l'Archet
May 22, 2023

MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

Recruiting
  • MDS/MPN
  • Azacitidine (AZA) with Ruxolitinib
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023

Atopic Dermatitis Trial in Culver City (Ruxolitinib cream, Vehicle)

Recruiting
  • Atopic Dermatitis
  • Culver City, California
    Science37
Jan 12, 2023

Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

Recruiting
  • Polycythemia Vera
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
May 19, 2023

Severe Checkpoint Inhibitor Pneumonitis Trial in Beijing (Corticosteroids, Corticosteroids and Ruxolitinib)

Recruiting
  • Severe Checkpoint Inhibitor Pneumonitis
  • Beijing, Beijing, China
    Department of Respiratory Medicine, Peking Union Medical College
Jun 12, 2023

Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)

Completed
  • Steroid Refractory GVHD
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Dec 15, 2022

Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)

Not yet recruiting
  • Graft-versus-host Disease
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023

Atopic Dermatitis Trial in East Syracuse, Arlington (ruxolitinib cream)

Recruiting
  • Atopic Dermatitis
  • ruxolitinib cream
  • East Syracuse, New York
  • +1 more
Jan 13, 2023

Ruxolitinib in Patients With Myelofibrosis

Completed
  • Myelofibrosis
  • (no location specified)
Jun 5, 2022

T-Cell Large Granular Lymphocyte Leukemia Trial in Columbus (Ruxolitinib)

Not yet recruiting
  • T-Cell Large Granular Lymphocyte Leukemia
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Oct 20, 2022

Graft Vs Host Disease, Graft-versus-host-disease, GVHD Trial in Saint Louis (Ruxolitinib)

Not yet recruiting
  • Graft Vs Host Disease
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 18, 2023

Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 26, 2022